FDAnews
www.fdanews.com/articles/181466-genmark-achieves-updated-ce-mark-for-its-eplex-blood-culture-identification-fungal-pathogen-panel

GenMark Achieves Updated CE Mark for its ePlex Blood Culture Identification Fungal Pathogen Panel

April 21, 2017

California–based Genmark have secured a CE mark or its ePlex blood culture identification fungal pathogen panel.

The device CE mark will include BCID gram-positive and gram-negative panels.

The ePlex systems are designed to support a broad range of molecular diagnostic tests with a compact, simple workstation and self-contained, disposable test cartridges. — Cynthia Jessup

View today's stories